Search research articles
Contact Us
Filters
Showing results (81-90 of 146) with videos related to
Page
of 15
Sort By:
BMC Infectious Diseases
|
May 23, 2019
The TransFLUas influenza transmission study in acute healthcare - recruitment rates and protocol adherence in healthcare workers and inpatients
Hila Schwarz, Jürg Böni, Roger D Kouyos, et al.
The Journal of Experimental Medicine
|
March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.
The Journal of Infectious Diseases
|
June 1, 2023
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
Jennifer A Brown, Anthony Hauser, Irene A Abela, et al.
The Journal of Infectious Diseases
|
July 24, 2004
Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies
Annette Oxenius, David A Price, Alexandra Trkola, et al.
Diagnostic Microbiology and Infectious Disease
|
August 2, 2015
Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strains
Dagmara W Lewandowska, Osvaldo Zagordi, Andrea Zbinden, et al.
Journal of Virology
|
March 15, 2013
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors
Axel Mann, Nikolas Friedrich, Anders Krarup, et al.
Cell Reports. Medicine
|
August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Magdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
Journal of Virology
|
June 16, 2005
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors
Peter Rusert, Herbert Kuster, Beda Joos, et al.
Endocrine
|
September 2, 2020
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients
Niccolò Buetti, Pierpaolo Trimboli, Timothy Mazzuchelli, et al.
Plos Pathogens
|
March 7, 2017
Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
David Beauparlant, Peter Rusert, Carsten Magnus, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 146) with videos related to
Sort By:
Page
of 15
BMC Infectious Diseases
|
May 23, 2019
The TransFLUas influenza transmission study in acute healthcare - recruitment rates and protocol adherence in healthcare workers and inpatients
Hila Schwarz, Jürg Böni, Roger D Kouyos, et al.
The Journal of Experimental Medicine
|
March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.
The Journal of Infectious Diseases
|
June 1, 2023
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
Jennifer A Brown, Anthony Hauser, Irene A Abela, et al.
The Journal of Infectious Diseases
|
July 24, 2004
Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies
Annette Oxenius, David A Price, Alexandra Trkola, et al.
Diagnostic Microbiology and Infectious Disease
|
August 2, 2015
Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strains
Dagmara W Lewandowska, Osvaldo Zagordi, Andrea Zbinden, et al.
Journal of Virology
|
March 15, 2013
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors
Axel Mann, Nikolas Friedrich, Anders Krarup, et al.
Cell Reports. Medicine
|
August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Magdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
Journal of Virology
|
June 16, 2005
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors
Peter Rusert, Herbert Kuster, Beda Joos, et al.
Endocrine
|
September 2, 2020
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients
Niccolò Buetti, Pierpaolo Trimboli, Timothy Mazzuchelli, et al.
Plos Pathogens
|
March 7, 2017
Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
David Beauparlant, Peter Rusert, Carsten Magnus, et al.
Page
of 15